Table 5 Outcomes of patients treated with ECMO compared to patients managed without ECMO
From: Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus
Variable | ECMO (n = 17) | Control (n = 18) | P value |
|---|---|---|---|
In-hospital mortality n (%) | 11 (64.7%) | 18 (100%) | 0.020 |
ICU length of stay (days)a | 22.5 [12.5–28.3] | 7 [4.3–11.5] | 0.001 |
Hospital length of stay (days) | 25 [6.3–56.5] | 47 [5–76.5] | 0.421 |
Time to death (days) | 32 [1–68] | 47 [1-93] | 0.422 |
Cause of death n (%) | |||
Septic shock/infection | 7 (41.2%) | 4 (22.2%) | 0.401 |
Refractory hypoxemia | 3 (17.6%) | 2 (11.1%) | 0.975 |
Others (undetermined) | 1 (5.9%) | 12 (66.7%) | 0.042 |